Roche NimbleGen
Products and services to the life science research market.
Launch date
Employees
Market cap
-
Enterprise valuation
$33—49m (Dealroom.co estimates Dec 2005.)
Madison Wisconsin (HQ)
| Date | Investors | Amount | Round |
|---|---|---|---|
$10.5m | Series B | ||
$12.5m | Series D | ||
$12.8m | Series F | ||
| N/A | $8.2m | Series F | |
| N/A | N/A | Acquisition | |
| Total Funding | $44.0m | ||